HSR Final Rule and Implications for Healthcare: Navigating New HSR Pre-Merger Notification Requirements
A live 90-minute CLE video webinar with interactive Q&A
This CLE webinar will guide healthcare counsel on the changing landscape for antitrust in the healthcare sector. The panel will discuss the Federal Trade Commission's (FTC) final rule significantly changing the Hart-Scott-Rodino (HSR) premerger notification report form as well as the premerger notification rules implementing the HSR Act. The panel will discuss what this means for healthcare and will offer best practices for understanding and navigating the changes under the final rule and ensuring compliance.
Outline
- Overview of the final rule changes
- Key changes to the HSR filing requirements
- Competitive overlaps
- Supply relationships
- Foreign subsidies
- Ownership structure
- Private equity
- Practical considerations and key takeaways
- Increased burden to prepare HSR filings
- Deal timelines
- Translating foreign language documents
- What if your transaction is close to being signed now
Benefits
The panel will review these and other key issues:
- What are the key changes to the HSR filing requirements?
- What are the practical implications for the healthcare industry of this rule change?
Faculty
Michael R. Greer
Shareholder
Hall Render Killian Heath & Lyman
Mr. Greer focuses his practice in the areas of antitrust law and managed care contracting. As part of his antitrust... | Read More
Mr. Greer focuses his practice in the areas of antitrust law and managed care contracting. As part of his antitrust practice, he has extensive experience in counseling health systems, hospitals and physicians on the antitrust requirements of mergers, acquisitions, joint ventures and provider networks. In this capacity, Mr. Greer frequently obtains clearance from the FTC and DOJ under the premerger reporting requirements of the Hart-Scott-Rodino (HSR) Act and defends providers in government antitrust investigations. During these government investigations, he manages complex procedural requirements, including large-scale document productions and electronic discovery and negotiates competition issues with the federal antitrust enforcement agencies. In addition, Mr. Greer routinely counsels healthcare providers on day-to-day antitrust compliance issues related to provider networks, managed care contracting, dominant firms and exchanges of competitively sensitive information, including “all or nothing” contracting, anti-tiering, anti-steering, gag clauses and price transparency. He also serves as part of an antitrust compliance monitoring team in monitoring antitrust agency consent orders.
Close
E. John Steren
Member
Epstein Becker & Green
Mr. Steren devotes a significant portion of his practice to helping healthcare organizations manage the antitrust risks... | Read More
Mr. Steren devotes a significant portion of his practice to helping healthcare organizations manage the antitrust risks of joint ventures and other business arrangements. He represents healthcare entities and providers in antitrust matters (counseling and litigation), including civil and government investigations and compliance with Hart-Scott-Rodino premerger notification requirements. He also focuses his practice on other complex commercial and civil litigation matters.
CloseEarly Discount (through 11/08/24)
Cannot Attend November 25?
Early Discount (through 11/08/24)
You may pre-order a recording to listen at your convenience. Recordings are available 48 hours after the webinar. Strafford will process CLE credit for one person on each recording. All formats include course handouts.